147 related articles for article (PubMed ID: 37952783)
1. Cost-effectiveness analysis of endovascular vs surgical arteriovenous fistula creation in the United States.
Mulaney-Topkar B; Ho VT; Sgroi MD; Garcia-Toca M; George EL
J Vasc Surg; 2024 Feb; 79(2):366-381.e1. PubMed ID: 37952783
[TBL] [Abstract][Full Text] [Related]
2. Comparison of post-creation procedures and costs between surgical and an endovascular approach to arteriovenous fistula creation.
Yang S; Lok C; Arnold R; Rajan D; Glickman M
J Vasc Access; 2017 Mar; 18(Suppl. 2):8-14. PubMed ID: 28362044
[TBL] [Abstract][Full Text] [Related]
3. Comparison between Surgical and Endovascular Hemodialysis Arteriovenous Fistula Interventions and Associated Costs.
Arnold RJG; Han Y; Balakrishnan R; Layton A; Lok CE; Glickman M; Rajan DK
J Vasc Interv Radiol; 2018 Nov; 29(11):1558-1566.e2. PubMed ID: 30293731
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness Analysis of Open Versus Endovascular Revascularization for Chronic Mesenteric Ischemia.
Patel RJ; Cui C; Khan MA; Willie-Permor D; Malas MB
Ann Vasc Surg; 2023 Aug; 94():347-355. PubMed ID: 36878356
[TBL] [Abstract][Full Text] [Related]
5. Endovascular Creation of an Arteriovenous Fistula (endoAVF) for Hemodialysis Access: First Results.
Radosa CG; Radosa JC; Weiss N; Schmidt C; Werth S; Hofmockel T; Plodeck V; Gatzweiler C; Laniado M; Hoffmann RT
Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1545-1551. PubMed ID: 28785804
[TBL] [Abstract][Full Text] [Related]
6. Endovascular Proximal Forearm Arteriovenous Fistula for Hemodialysis Access: Results of the Prospective, Multicenter Novel Endovascular Access Trial (NEAT).
Lok CE; Rajan DK; Clement J; Kiaii M; Sidhu R; Thomson K; Buldo G; Dipchand C; Moist L; Sasal J;
Am J Kidney Dis; 2017 Oct; 70(4):486-497. PubMed ID: 28624422
[TBL] [Abstract][Full Text] [Related]
7. Early clinical experience and comparison between percutaneous and surgical arteriovenous fistula.
Habib SG; Jano A; Ali AA; Phillips A; Pinter J; Yuo TH
J Vasc Surg; 2023 Sep; 78(3):766-773. PubMed ID: 37230183
[TBL] [Abstract][Full Text] [Related]
8. Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?
Albright RH; Joseph RM; Wukich DK; Armstrong DG; Fleischer AE
Clin Orthop Relat Res; 2020 Dec; 478(12):2869-2888. PubMed ID: 32694315
[TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of moderate to severe psoriasis therapy with etanercept and ustekinumab in the United States.
Villacorta R; Hay JW; Messali A
Pharmacoeconomics; 2013 Sep; 31(9):823-39. PubMed ID: 23975739
[TBL] [Abstract][Full Text] [Related]
11. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness Analysis of Venetoclax in Combination with Azacitidine Versus Azacitidine Monotherapy in Patients with Acute Myeloid Leukemia Who are Ineligible for Intensive Chemotherapy: From a US Third Party Payer Perspective.
Pratz KW; Chai X; Xie J; Yin L; Nie X; Montez M; Iantuono E; Downs L; Ma E
Pharmacoeconomics; 2022 Aug; 40(8):777-790. PubMed ID: 35696071
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Laparoscopic Hysterectomy With Morcellation Compared With Abdominal Hysterectomy for Presumed Myomas.
Rutstein SE; Siedhoff MT; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL; Wheeler SB
J Minim Invasive Gynecol; 2016 Feb; 23(2):223-33. PubMed ID: 26475764
[TBL] [Abstract][Full Text] [Related]
15. Multi-Center Two-Year Patency Outcomes of Endovascular Arteriovenous Fistulas (endoAVF) Created with a 4 French System.
Klein E; Repko B; Alvarez A; Inston N; Jones R; Rajan DK
Cardiovasc Intervent Radiol; 2024 Jun; ():. PubMed ID: 38839640
[TBL] [Abstract][Full Text] [Related]
16. A systematic review aggregated data and individual participant data meta-analysis of percutaneous endovascular arteriovenous fistula.
Bontinis A; Bontinis V; Koutsoumpelis A; Wilmink T; Giannopoulos A; Rafailidis V; Chorti A; Ktenidis K
J Vasc Surg; 2023 Apr; 77(4):1252-1261.e3. PubMed ID: 36328141
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States.
Chatterjee A; Shapouri S; Manzoor BS; Ravelo A; Sail K; Qendri V; van de Wetering G; Davids MS
J Manag Care Spec Pharm; 2021 Nov; 27(11):1532-1544. PubMed ID: 34714110
[No Abstract] [Full Text] [Related]
18. The Cost-Effectiveness of Bimodal Stimulation Compared to Unilateral and Bilateral Cochlear Implant Use in Adults with Bilateral Severe to Profound Deafness.
Theriou C; Fielden CA; Kitterick PT
Ear Hear; 2019; 40(6):1425-1436. PubMed ID: 30998548
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United States.
Qi CZ; Bollu V; Yang H; Dalal A; Zhang S; Zhang J
Clin Ther; 2021 Aug; 43(8):1300-1319.e8. PubMed ID: 34380609
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
